Bilateral salpingo-oophorectomy (BSO) is the standard risk-reducing intervention recommended for individuals carrying germline mutations in the BRCA1 or BRCA2 genes, as well as for those with other high-risk gene mutations or a diagnosis of Lynch syndrome. This evidence concerns the gene BRCA1 and Lynch syndrome.